Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gelatin-Polyvinyl Alcohol Microspheres for Controlled and Sustained Release of BMP-2 and VEGF Enhance Osteogenic and Angiogenic Cell Differentiation.

Gels (Basel, Switzerland)·2026

Same author

Controlling the Bioprinting Efficiency of Alginate-Gelatin by Varying Hydroxyapatite Concentrations to Fabricate Bioinks for Bone Tissue Engineering.

Polymers·2026

Same author

Electrically conductive and mechanoactive scaffolds synergistically enhance osteogenic cell responses under mechanical stimulation.

Biomaterials science·2025

Same author

Electrospun PLGA fibers with calcium phosphate nanoparticles: effects of nanoparticle crystallinity and carbonate content on osteogenic activity.

Biomaterials science·2025

Same author

Notch2 Deletion Compromises Epithelial Integrity and Enamel Formation in Rodent Incisors.

Cells·2025

Same author

Organotypic 3D Cellular Models Mimicking the Epithelio-Ectomesenchymal Bilayer During Odontogenesis.

Tissue engineering. Part A·2024

Search research articles

Related Experiment Video

Updated: Mar 29, 2026

Bridging the Bio-Electronic Interface with Biofabrication

Bridging the Bio-Electronic Interface with Biofabrication

Published on: June 6, 2012

Living Tissues by Design: The Rise of Hybrid Models in Biofabrication.

Varvara Platania¹, Argyro Lamprou¹, Isaac Maximiliano Bugueno^1,2

¹Orofacial Development and Regeneration, Institute of Oral Biology, Faculty of Medicine, Centre for Dental Medicine, University of Zurich, 8032 Zurich, Switzerland.

Journal of Functional Biomaterials

|March 27, 2026

Summary

Advanced hybrid tissue models integrate organoids with biofabrication for improved disease modeling. These next-generation systems combine self-organization with engineered vascularization and mechanical control for greater physiological relevance.

Keywords:

3D bioprinting biofabrication hybrid tissue models organ-on-chip organoids self-organisation spheroids

More Related Videos

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication

Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication

Published on: August 16, 2024

Related Experiment Videos

Last Updated: Mar 29, 2026

Bridging the Bio-Electronic Interface with Biofabrication

Bridging the Bio-Electronic Interface with Biofabrication

Published on: June 6, 2012

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication

Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication

Published on: August 16, 2024

Area of Science:

Tissue Engineering and Regenerative Medicine
Biotechnology and Biofabrication
In Vitro Disease Modeling

Background:

Current in vitro tissue models lack the structural, vascular, and mechanical complexity of native human tissues, limiting their physiological relevance.
Self-organizing cultures (spheroids, organoids) offer cellular complexity but lack controlled geometry, vascularization, and mechanical environments.
Biofabrication (3D bioprinting, organ-on-chip devices) provides spatial control and perfusion but often misses full cellular diversity and self-organization.

Purpose of the Study:

To review recent advances (2020-2025) in hybrid cellular and tissue models.
To highlight progress in organoid vascularization, bioprinting of vascularized constructs, and organ-on-chip integration.
To outline challenges and priorities for next-generation hybrid tissue models.

Main Methods:

Integration of self-organizing biological units (organoids, spheroids) into engineered scaffolds or microfluidic platforms.
Advances in bioink chemistry for improved scaffold properties and cell viability.
Development of sacrificial printing techniques for creating perfusable vascular networks.
Enhancement of chip-organoid interfaces for functional tissue integration.

Main Results:

Hybrid approaches successfully combine biological relevance with architectural fidelity and functional control.
Recent innovations enable the creation of perfusable, multicompartment tissues with enhanced structural and vascular complexity.
These advanced models show promise for more accurate disease modeling and preclinical testing.

Conclusions:

Hybrid tissue models represent a significant leap forward in recapitulating native tissue complexity in vitro.
Continued progress in bioink development, vascularization strategies, and microfluidic integration is crucial.
Next-generation hybrid models are essential for advancing personalized medicine and drug discovery.